AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 9224783 — intervention group
Group type: EXPERIMENTAL
Intervention: [14C]avitriptan
Number of subjects: 0
Study 8095240 — intervention group
Group type: EXPERIMENTAL
Intervention: formoterol (24 micrograms)
Number of subjects: 12
Study 8095240 — intervention group
Group type: EXPERIMENTAL
Intervention: salbutamol (400 micrograms)
Number of subjects: 12
Study 8095240 — intervention group
Group type: EXPERIMENTAL
Intervention: fenoterol (400 micrograms)
Number of subjects: 12
Study 8095240 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 12
Study 3689015 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefamandole
Number of subjects: 1030
Study 3689015 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefazolin
Number of subjects: 1030
Study 3689015 — intervention group
Group type: EXPERIMENTAL
Intervention: Gentamicin
Number of subjects: 1030
Study 30124733 — intervention group
Group type: EXPERIMENTAL
Intervention: Nature-based regimen (NR) containing natural oils, beeswax, and witch hazel, and day & night creams containing natural oils, glycerin, and botanical anti-inflammatories
Number of subjects: 120
Study 30124733 — intervention group
Group type: COMPARATOR
Intervention: Synthetic dermatologist-recommended regimen (CR) containing cetyl alcohol, sodium lauryl sulphate-containing cleanser and glycerin, polyisobutene-containing lotion
Number of subjects: 120
Study 26950097 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive‐behavioral group therapy (CBGT)
Number of subjects: 108
Study 26950097 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness‐based stress reduction (MBSR)
Number of subjects: 108
Study 26950097 — intervention group
Group type: COMPARATOR
Intervention: Waitlist (WL)
Number of subjects: 108
Study 24554416 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Rehabilitation (CR) program
Number of subjects: 15
Study 24554416 — intervention group
Group type: COMPARATOR
Intervention: Placebo intervention
Number of subjects: 15
Study 22843010 — intervention group
Group type: EXPERIMENTAL
Intervention: Salicylic sugar powder
Number of subjects: 143
Study 22843010 — intervention group
Group type: COMPARATOR
Intervention: Natural drying
Number of subjects: 143
Study 22843010 — intervention group
Group type: COMPARATOR
Intervention: Alcohol
Number of subjects: 143
Study 20819314 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous IFN-gamma injection
Number of subjects: 148
Study 17670998 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative care intervention
Number of subjects: 1801
Study 17670998 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1801
Study 15604156 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardised safety consultation and provision of safety equipment (stair gates, fire guards, smoke alarms, cupboard locks, window locks)
Number of subjects: 3428
Study 15604156 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardised safety consultation and provision of safety equipment
Number of subjects: 3428
Study 15604156 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 3428
Study 12396255 — intervention group
Group type: EXPERIMENTAL
Intervention: Unusual experiences
Number of subjects: 80
Study 12396255 — intervention group
Group type: EXPERIMENTAL
Intervention: Impulsive non-conformity
Number of subjects: 80
Study 12396255 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive disorganization
Number of subjects: 80
Study 12396255 — intervention group
Group type: EXPERIMENTAL
Intervention: Introvertive anhedonia
Number of subjects: 80
Study 8311216 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal anaesthesia
Number of subjects: 32
Study 8311216 — intervention group
Group type: COMPARATOR
Intervention: Epidural anaesthesia
Number of subjects: 32
Study 8311216 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 32
Study 3138441 — intervention group
Group type: EXPERIMENTAL
Intervention: BCAA-enriched amino acid solution
Number of subjects: 173
Study 31034264 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-weeks moderate-intensity resistance training
Number of subjects: 24
Study 31034264 — intervention group
Group type: COMPARATOR
Intervention: Control period
Number of subjects: 24
Study 30852469 — intervention group
Group type: EXPERIMENTAL
Intervention: Finger tapping training with a metronome set to 20% faster pace than pre-training walking cadence
Number of subjects: 41
Study 30852469 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm swing training with a metronome
Number of subjects: 41
Study 30852469 — intervention group
Group type: COMPARATOR
Intervention: Control condition (no training)
Number of subjects: 41
Study 27768643 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcanalicular laser‐assisted dacryocystorhinostomy with endonasal augmentation without intubation
Number of subjects: 60
Study 27768643 — intervention group
Group type: COMPARATOR
Intervention: Transcanalicular laser‐assisted dacryocystorhinostomy with endonasal augmentation with bicanalicular intubation
Number of subjects: 60
Study 26071234 — intervention group
Group type: EXPERIMENTAL
Intervention: CRT-D
Number of subjects: 1820
Study 26071234 — intervention group
Group type: COMPARATOR
Intervention: ICD
Number of subjects: 1820
Study 23259514 — intervention group
Group type: EXPERIMENTAL
Intervention: Kava (180 mg of kavalactones)
Number of subjects: 22
Study 23259514 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxazepam (30 mg)
Number of subjects: 22
Study 23259514 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 21620099 — intervention group
Group type: EXPERIMENTAL
Intervention: Biopsy group
Number of subjects: 113
Study 21620099 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 113
Study 19452698 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbar traction for 24 weeks
Number of subjects: 263
Study 19452698 — intervention group
Group type: COMPARATOR
Intervention: Sertraline hydrochloride tablets for 24 weeks
Number of subjects: 263
Study 16412876 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus‐eluting stents (SES)
Number of subjects: 322
Study 16412876 — intervention group
Group type: COMPARATOR
Intervention: Bare-metal stents (BMS)
Number of subjects: 322
Study 15221403 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive torque at 63% of v(max)
Number of subjects: 22
Study 15221403 — intervention group
Group type: EXPERIMENTAL
Intervention: Size-normalized passive torque at 63% of v(max)
Number of subjects: 22
Study 15221403 — intervention group
Group type: EXPERIMENTAL
Intervention: Size-normalized passive torque at 77% of v(max)
Number of subjects: 22
Study 15221403 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrostatic lift at 63% of v(max)
Number of subjects: 22
Study 15221403 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive torque and hydrostatic lift
Number of subjects: 22
Study 15221403 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrostatic lift and passive torque
Number of subjects: 22
Study 15221403 — intervention group
Group type: EXPERIMENTAL
Intervention: Corrected for body size
Number of subjects: 22
Study 11726450 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.125% bupivacaine plus 0.5 microg/mL sufentanil (BS group)
Number of subjects: 60
Study 11726450 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.125% ropivacaine plus 0.5 microg/mL sufentanil (RS group)
Number of subjects: 60
Study 11726450 — intervention group
Group type: COMPARATOR
Intervention: 0.2% ropivacaine (R group)
Number of subjects: 60
Study 9524436 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (n = 171)
Number of subjects: 360
Study 9524436 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 189)
Number of subjects: 360
Study 8478307 — intervention group
Group type: EXPERIMENTAL
Intervention: Dirithromycin 500 mg once daily for 7 days
Number of subjects: 304
Study 8478307 — intervention group
Group type: COMPARATOR
Intervention: Erythromycin 250 mg four times daily for 7 days
Number of subjects: 304
Study 8478307 — intervention group
Group type: EXPERIMENTAL
Intervention: Dirithromycin 500 mg once daily for 7 days (European study)
Number of subjects: 304
Study 8478307 — intervention group
Group type: COMPARATOR
Intervention: Erythromycin (European study)
Number of subjects: 304
Study 8478307 — intervention group
Group type: EXPERIMENTAL
Intervention: Dirithromycin 500 mg once daily for 7 days (Italian study)
Number of subjects: 304
Study 8478307 — intervention group
Group type: COMPARATOR
Intervention: Miocamycin 600 mg twice daily for 7 days (Italian study)
Number of subjects: 304
Study 3072779 — intervention group
Group type: EXPERIMENTAL
Intervention: Closure and vagotomy (truncal vagotomy in 71 patients, proximal gastric vagotomy in 8 patients)
Number of subjects: 162
Study 3072779 — intervention group
Group type: COMPARATOR
Intervention: Simple closure
Number of subjects: 162
Study 3072779 — intervention group
Group type: EXPERIMENTAL
Intervention: Closure and vagotomy
Number of subjects: 162
Study 3072779 — intervention group
Group type: EXPERIMENTAL
Intervention: Definitive surgery (closure and vagotomy)
Number of subjects: 162
Study 31634080 — intervention group
Group type: EXPERIMENTAL
Intervention: Resilient students
Number of subjects: 117539
Study 31634080 — intervention group
Group type: EXPERIMENTAL
Intervention: Low performing students
Number of subjects: 117539
Study 31634080 — intervention group
Group type: EXPERIMENTAL
Intervention: Student confidence with reading
Number of subjects: 117539
Study 31634080 — intervention group
Group type: EXPERIMENTAL
Intervention: Early literacy activities
Number of subjects: 117539
Study 28520754 — intervention group
Group type: EXPERIMENTAL
Intervention: IWT + high-dose post-exercise milk product intake (HD, n = 13)
Number of subjects: 37
Study 28520754 — intervention group
Group type: EXPERIMENTAL
Intervention: IWT + low-dose post-exercise milk product intake (LD, n = 12)
Number of subjects: 37
Study 28520754 — intervention group
Group type: COMPARATOR
Intervention: IWT alone (CNT, n = 12)
Number of subjects: 37
Study 26171983 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal 8 IU OT
Number of subjects: 16
Study 26171983 — intervention group
Group type: COMPARATOR
Intervention: Intranasal 24 IU OT
Number of subjects: 16
Study 26171983 — intervention group
Group type: COMPARATOR
Intervention: Intravenous 1 IU OT
Number of subjects: 16
Study 26171983 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 22157215 — intervention group
Group type: EXPERIMENTAL
Intervention: SLNB+ALND (GrA)
Number of subjects: 199
Study 22157215 — intervention group
Group type: EXPERIMENTAL
Intervention: SLNB+ALND (GrB)
Number of subjects: 199
Study 22157215 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed ALND (SubGrB2a)
Number of subjects: 199
Study 22157215 — intervention group
Group type: COMPARATOR
Intervention: SLNB (SubGrB2b)
Number of subjects: 199
Study 22157215 — intervention group
Group type: EXPERIMENTAL
Intervention: Node-negative ALND (SubGrA2)
Number of subjects: 199
Study 22157215 — intervention group
Group type: EXPERIMENTAL
Intervention: Node-positive ALND (A1+B1+B2a)
Number of subjects: 199
Study 22978443 — intervention group
Group type: EXPERIMENTAL
Intervention: Research arms (specific arms not detailed)
Number of subjects: 0
Study 22978443 — intervention group
Group type: EXPERIMENTAL
Intervention: New research arm (specific details not provided)
Number of subjects: 0
Study 22978443 — intervention group
Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 0
Study 19566638 — intervention group
Group type: EXPERIMENTAL
Intervention: Support program for stress management (homework for 3 months, nurse feedback monthly)
Number of subjects: 140
Study 19566638 — intervention group
Group type: EXPERIMENTAL
Intervention: Support program for stress management
Number of subjects: 140
Study 19566638 — intervention group
Group type: COMPARATOR
Intervention: Control group (only booklet)
Number of subjects: 140
Study 17513626 — intervention group
Group type: EXPERIMENTAL
Intervention: Caudal clonidine (2 mcg/kg) combined with 1.0 mL/kg of 0.2% ropivacaine with epinephrine
Number of subjects: 60
Study 17513626 — intervention group
Group type: COMPARATOR
Intervention: Caudal morphine (50 mcg/kg) combined with 1.0 mL/kg of 0.2% ropivacaine with epinephrine
Number of subjects: 60
Study 17513626 — intervention group
Group type: COMPARATOR
Intervention: Caudal hydromorphone (10 mcg/kg) combined with 1.0 mL/kg of 0.2% ropivacaine with epinephrine
Number of subjects: 60
Study 15593020 — intervention group
Group type: COMPARATOR
Intervention: Corticosteroids
Number of subjects: 0
Study 15593020 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytotoxic agents
Number of subjects: 0
Study 15593020 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone with chlorambucil or cyclophosphamide (6-month treatment alternating every other month)
Number of subjects: 0
Study 15593020 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine
Number of subjects: 0
Study 15593020 — intervention group
Group type: EXPERIMENTAL
Intervention: Long acting ACTH preparation (1 year treatment)
Number of subjects: 0
Study 11437859 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisinopril (ACE inhibitor)
Number of subjects: 299
Study 11437859 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 299
Study 9931685 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous glutamine substitution
Number of subjects: 0
Study 9931685 — intervention group
Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 0
Study 7823566 — intervention group
Group type: COMPARATOR
Intervention: Connected speech fragments
Number of subjects: 0
Study 7823566 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 msec vowel onset stimulus
Number of subjects: 0
Study 7823566 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 msec post-onset stimulus
Number of subjects: 0
Study 7823566 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 msec whole vowel stimulus
Number of subjects: 0
Study 3346287 — intervention group
Group type: EXPERIMENTAL
Intervention: Sliding screw‐plate device
Number of subjects: 127
Study 3346287 — intervention group
Group type: COMPARATOR
Intervention: Double divergent pins
Number of subjects: 127
Study 3346287 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 127
Study 29564625 — intervention group
Group type: EXPERIMENTAL
Intervention: Palonosetron
Number of subjects: 108
Study 29564625 — intervention group
Group type: COMPARATOR
Intervention: Ondansetron
Number of subjects: 108
Study 28204912 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat/calorie meal
Number of subjects: 28
Study 28204912 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat/calorie meal
Number of subjects: 28
Study 28204912 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-fat/standard-calorie meals
Number of subjects: 28
Study 28204912 — intervention group
Group type: COMPARATOR
Intervention: Fasted condition
Number of subjects: 28
Study 25327942 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed cord clamping (DCC, 2-3 min after birth)
Number of subjects: 104
Study 25327942 — intervention group
Group type: COMPARATOR
Intervention: Early cord clamping (ECC, <30 s)
Number of subjects: 104
Study 25327942 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed cord clamping (DCC)
Number of subjects: 104
Study 23148286 — intervention group
Group type: EXPERIMENTAL
Intervention: Atazanavir/ritonavir (atazanavir/r)
Number of subjects: 646
Study 23148286 — intervention group
Group type: COMPARATOR
Intervention: Efavirenz
Number of subjects: 646
Study 20816039 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunctive aripiprazole (2‐20 mg/d)
Number of subjects: 737
Study 20816039 — intervention group
Group type: COMPARATOR
Intervention: Adjunctive placebo
Number of subjects: 737
Study 18427147 — intervention group
Group type: EXPERIMENTAL
Intervention: Risedronate 35 mg once weekly
Number of subjects: 87
Study 18427147 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 87
Study 16532712 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin II receptor blockers (ARB)
Number of subjects: 2438
Study 12692113 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV testing
Number of subjects: 330
Study 12692113 — intervention group
Group type: COMPARATOR
Intervention: Immediate colposcopy
Number of subjects: 330
Study 12692113 — intervention group
Group type: COMPARATOR
Intervention: Repeat cytology of HSIL
Number of subjects: 330
Study 11035984 — intervention group
Group type: EXPERIMENTAL
Intervention: Progesterone and progestins; specific dosage and duration not mentioned.
Number of subjects: 0
Study 11035984 — intervention group
Group type: COMPARATOR
Intervention: Estrogen; specific dosage and duration not mentioned.
Number of subjects: 0
Study 8933313 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone (2 g daily with 1 g probenecid)
Number of subjects: 194
Study 8933313 — intervention group
Group type: COMPARATOR
Intervention: Cefazolin (2 g daily with 1 g probenecid)
Number of subjects: 194
Study 1416576 — intervention group
Group type: EXPERIMENTAL
Intervention: r‐HuEPO (100 to 200 U/kg body weight), intravenously or subcutaneously, three times per week for up to 12 weeks
Number of subjects: 297
Study 1416576 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 297
Study 3993879 — intervention group
Group type: EXPERIMENTAL
Intervention: Sedation with etomidate
Number of subjects: 40
Study 3993879 — intervention group
Group type: EXPERIMENTAL
Intervention: Sedation with thiopental
Number of subjects: 40
Study 3993879 — intervention group
Group type: EXPERIMENTAL
Intervention: EEG monitoring
Number of subjects: 40
Study 3993879 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with septicaemia
Number of subjects: 40
Study 3993879 — intervention group
Group type: EXPERIMENTAL
Intervention: Spectral analysis and computed parameters
Number of subjects: 40
Study 31208393 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05% cyclosporine (CN)
Number of subjects: 153
Study 31208393 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% diquafosol (DQ)
Number of subjects: 153
Study 29134744 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral sodium propionate (6845 mg)
Number of subjects: 18
Study 29134744 — intervention group
Group type: COMPARATOR
Intervention: Sodium chloride (4164 mg)
Number of subjects: 18
Study 27590594 — intervention group
Group type: EXPERIMENTAL
Intervention: Altruism expressed by acceptors and decliners
Number of subjects: 39
Study 27590594 — intervention group
Group type: EXPERIMENTAL
Intervention: Overriding personal needs in decliners
Number of subjects: 39
Study 27590594 — intervention group
Group type: EXPERIMENTAL
Intervention: Pure altruism in acceptors
Number of subjects: 39
Study 27590594 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypothetical altruism amongst acceptors
Number of subjects: 39
Study 27590594 — intervention group
Group type: EXPERIMENTAL
Intervention: Weak altruism amongst acceptors
Number of subjects: 39
Study 27590594 — intervention group
Group type: EXPERIMENTAL
Intervention: Conditional altruism amongst acceptors
Number of subjects: 39
Study 27590594 — intervention group
Group type: EXPERIMENTAL
Intervention: Sense of duty to participate
Number of subjects: 39
Study 27590594 — intervention group
Group type: EXPERIMENTAL
Intervention: Understanding of trial rationale
Number of subjects: 39
Study 23334387 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle maintenance program (n = 112)
Number of subjects: 210
Study 23334387 — intervention group
Group type: COMPARATOR
Intervention: Standard care (n = 98)
Number of subjects: 210
Study 22767424 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral system of psychotherapy (CBASP) + ADM
Number of subjects: 785
Study 22767424 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief supportive psychotherapy (BSP) + ADM
Number of subjects: 785
Study 22767424 — intervention group
Group type: COMPARATOR
Intervention: ADM only
Number of subjects: 785
Study 22767424 — intervention group
Group type: EXPERIMENTAL
Intervention: Any treatment preference
Number of subjects: 785
Study 22767424 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication only preference
Number of subjects: 785
Study 22767424 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment preference
Number of subjects: 785
Study 20039429 — intervention group
Group type: EXPERIMENTAL
Intervention: mycophenolate mofetil (target dosage 3 gm/day)
Number of subjects: 370
Study 20039429 — intervention group
Group type: EXPERIMENTAL
Intervention: intravenous cyclophosphamide (0.5‐1.0 gm/m(2)/month)
Number of subjects: 370
Study 17321816 — intervention group
Group type: EXPERIMENTAL
Intervention: modified constraint‐induced movement therapy (mCIMT)
Number of subjects: 26
Study 17321816 — intervention group
Group type: COMPARATOR
Intervention: traditional rehabilitation
Number of subjects: 26
Study 15333078 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral d,l‐sotalol (196 +/- 42 mg/day for 7 days)
Number of subjects: 19
Study 15333078 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated)
Number of subjects: 19
Study 15333078 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral d,l‐sotalol (216 +/- 51 mg/day)
Number of subjects: 19
Study 11605744 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT) in adherent PBMC group (n = 20)
Number of subjects: 30
Study 11605744 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT) in total PBMC group (n = 9)
Number of subjects: 30
Study 11605744 — intervention group
Group type: COMPARATOR
Intervention: In vitro culture with 10(‐8) M 17beta‐estradiol or tibolone
Number of subjects: 30
Study 11819342 — intervention group
Group type: EXPERIMENTAL
Intervention: Yinchenhao Chengqi decoction combined with endoscopic sphincterotomy (EST)
Number of subjects: 21
Study 11819342 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic sphincterotomy (EST)
Number of subjects: 21
Study 8085482 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured Learning Therapy (SLT)
Number of subjects: 18
Study 8085482 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 18
Study 2665639 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc gluconate (23 mg of elemental zinc lozenges taken every 2 hours)
Number of subjects: 0
Study 2665639 — intervention group
Group type: COMPARATOR
Intervention: Placebo (taste-matched sucrose octaacetate lozenges)
Number of subjects: 0
Study 595718 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet
Number of subjects: 100
Study 595718 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolbutamide
Number of subjects: 100
Study 595718 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbutamide
Number of subjects: 100